Document is current
Any future updates will be listed below
-
Authors
Wang, Yan https://orcid.org/0000-0002-3136-3109
Allsop, Matthew J. https://orcid.org/0000-0002-7399-0194
Epstein, Joel B.
Howell, Doris https://orcid.org/0000-0002-0683-8715
Rapoport, Bernardo L. https://orcid.org/0000-0001-7610-3653
Schofield, Penelope https://orcid.org/0000-0001-9495-9543
Van Sebille, Ysabella https://orcid.org/0000-0002-5803-3230
Thong, Melissa S.Y. https://orcid.org/0000-0002-6987-705X
Walraven, Iris https://orcid.org/0000-0002-6083-730X
Ryan Wolf, Julie https://orcid.org/0000-0002-0592-7820
van den Hurk, Corina J.G. https://orcid.org/0000-0002-7802-1034
- License Information
-
More Information
Article History
Received: 26 April 2023
Accepted: 11 February 2024
First Online: 22 February 2024
Declarations
:
: Dr. van den Hurk received institutional implementation and research grants for symptom monitoring from AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Ipsen, and Merck. Dr. Doris Howell is on the Scientific Advisory Board of Carevive Systems, Inc. and has been a consultant to this company in previous years.
